Intra-Cellular Therapies Inc
NASDAQ:ITCI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intra-Cellular Therapies Inc
NASDAQ:ITCI
|
US |
|
St Barbara Ltd
ASX:SBM
|
AU |
|
C
|
China Construction Bank Corp
HKEX:939
|
CN |
|
Genetec Corp
TSE:4492
|
JP |
|
Emerald Holding Inc
NYSE:EEX
|
US |
|
GeneDx Holdings Corp
NASDAQ:WGS
|
US |
|
W
|
Woori Technology Investment Co Ltd
KOSDAQ:041190
|
KR |
|
Micreed Co Ltd
TSE:7687
|
JP |
|
A
|
Australian Critical Minerals Ltd
ASX:ACM
|
AU |
|
Mapfre SA
OTC:MPFRY
|
ES |
|
S
|
Semperit Holding AG
VSE:SEM
|
AT |
|
Northern Graphite Corp
XTSX:NGC
|
CA |
|
E
|
Epicon Bhd
KLSE:EPICON
|
MY |
|
C
|
Changhae Ethanol Co Ltd
KOSDAQ:004650
|
KR |
|
Lucara Diamond Corp
TSX:LUC
|
CA |
|
F
|
Fonciere Inea SA
PAR:INEA
|
FR |
|
Comsys Holdings Corp
OTC:CMSYF
|
JP |
Bankruptcy Probability
Intra-Cellular Therapies Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Intra-Cellular Therapies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Intra-Cellular Therapies Inc
NASDAQ:ITCI
|
14B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Intra-Cellular Therapies Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Intra-Cellular Therapies Inc has no debt.
You can find a full breakdown on its Balance Sheet.
